International Journal of Nursing Education and Research

E. Shanees ¹

Affiliations
1 Vice Principal, Manoj Jain Memorial College of Nursing Sciences and Research Center, Satna, Madhya Pradesh., IN

Abstract

Chagas disease, also known as American trypanosomiasis, is a potentially life-threatening illness caused by the protozoan parasite Trypanosoma cruzi. An estimated 6 to 7 million people worldwide are infected with T. cruzi. Chagas disease is found mainly in endemic areas of 21 continental Latin American countries, where it is mostly transmitted when humans come into contact with faeces and/or urine of infected blood-sucking triatomine bugs (vector-borne transmission)1. Chagas disease is named after the Brazilian physician Carlos Chagas, who discovered the disease in 19092. Trypanosoma cruzi infection is curable if treatment is initiated soon after infection. In chronic patients, antiparasitic treatment can potentially prevent or curb disease progression and prevent transmission. Chagas disease patients are at risk of severe COVID-19 manifestations and should be a priority group to be vaccinated because the SARS-CoV-2 can cause myocarditis and the chronic Chagas disease typically originates a pro-thrombotic status, cardiac alterations and secondary thrombotic strokes

Keywords

Chagas disease, Trypanosomiasis, Trypanosome cruzi, Triatomine bug, COVID 19, SARS-Cov-2, Myocarditis, Pro thrombotic status, Vector-borne.

Full Text

     

E. Shanees ¹

Affiliations
1 Vice Principal, Manoj Jain Memorial College of Nursing Science and Research Center, Satna, Madhya Pradesh., IN

Abstract

The National Rosacea Society (NRS) designates April as Rosacea Awareness Month to educate the public on the impact of the chronic and widespread facial disorder that is estimated to affect more than 16 million Americans1. The goal of Rosacea Awareness Month is to spread public education on this disease so that more people who may have rosacea seek medical help before it gets worse, and so those whose lives are affected can find greater public acceptance and understanding.1 Rosacea is a chronic inflammatory skin condition that usually affects the face and fortunately there is a range of medical therapies that may effectively address each individual case2. Through habit, many patients may unknowingly continue with therapy that is not as effective as it could be, when there may be newer medications that achieve more successful results as well as therapy combinations that offer excellent synergistic effects.

Keywords

Rosacea, National Rosacea Society (NRS), Awareness, Facial disorder, Chronic inflammation.

Full Text

     

M. R. Sushil ¹, E. Shanees ²

Affiliations
1 Associate Professor, Vindhya College of Nursing, Satna., IN
2 Vice principal, Manoj Jain Memorial College of Nursing, Satna, IN

Abstract

Background: Minimally invasive surfactant therapy (MIST) is a new mode of surfactant administration without intubation to spontaneously breathing preterm infants with respiratory distress syndrome (RDS).1 Use of this therapy is growing in Neonatal Units, as it reduces the intubation rate and the pathology associated with intubation and allows surfactant to be administered to patients in need2 Objective: The present study aimed to assess the effectiveness of video assisted teaching program on knowledge regarding minimally invasive surfactant therapy among nursing students in selected nursing colleges, Satna. Methodology: Pre-experimental, one group pre-test post-test design was adopted for this study. 40 student Nurses studying in selected colleges, Satna were selected by using simple random sampling method for this study. A pre test was conducted by using structured knowledge questionnaire and on the same day the video assisted teaching program regarding minimally invasive surfactant therapy was administered to them. After 7 days, post test was conducted with the same questionnaire for the same group of student nurses to assess the effectiveness of video assisted teaching program. Result: The mean score in the post test is 25.2 and the mean score in the pre test is 8.2. The calculated value of t is 31.8 which is highly significant. The result confirms that the video assisted teaching program was effective significantly in improving the knowledge on minimally invasive surfactant therapy among the student nurses.

Keywords

Effectiveness, minimally invasive, surfactant therapy, respiratory distress syndrome, video assisted teaching, student nurses.

Full Text

     

E. Shanees ¹

Affiliations
1 Vice Principal, Manoj Jain Memorial College of Nursing Science and Research Center, Satna, Madhya Pradesh., IN

Abstract

Marburg virus disease (MVD) is a rare but severe hemorrhagic fever which affects both people and non-human primates. MVD is caused by the Marburg virus, a genetically unique zoonotic (or, animal-borne) RNA virus of the filovirus family1. The six species of Ebola virus are the only other known members of the filovirus family. Marburg virus was first recognized in 19671. Two fatal cases of Marburg virus disease (MVD) were reported from Ashanti region, Ghana. On 28 June 2022, these cases were notified to health authorities as suspected viral hemorrhagic fever (VHF) cases and tested positive for Marburg virus on 1 July 20222. The reservoir host of Marburg virus is the African fruit bat, Rousettus aegyptiacus. Marburg virus is the causative agent of Marburg virus disease (MVD), a disease with a case fatality ratio of up to 88%, but can be much lower with good patient care. Marburg and Ebola viruses are both members of the Filoviridae family (filovirus). Though caused by different viruses, the two diseases are clinically similar1. The incubation period (interval from infection to onset of symptoms) varies from 2 to 21 days2. Many patients develop severe haemorrhagic manifestations between 5 and 7 days, and fatal cases usually have some form of bleeding, often from multiple areas. It can be difficult to clinically distinguish MVD from other infectious diseases such as malaria, typhoid fever, shigellosis, meningitis and other viral haemorrhagic fevers. Currently there are no vaccines or antiviral treatments approved for MVD2. However, supportive care – rehydration with oral or intravenous fluids – and treatment of specific symptoms, improves survival. Healthcare workers caring for patients with suspected or confirmed Marburg virus should apply extra infection control measures to prevent contact with the patient’s blood and body fluids and contaminated surfaces or materials such as clothing and bedding

Keywords

Marburg Virus, MVD, Rousettus aegyptiacus, Filoviridae, Haemorrhagic fever, Zoonotic.

Full Text